TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Thu Apr 16

NL

Article

gbudwell published an article 12:44 AM

Johnson & Johnson's Earnings: The Good, The Bad and The Ugly

Johnson & Johnson reported a mixed first-quarter this week. Here is what investors need to know going forward.

Mon Apr 13

NL

Article

gbudwell published an article 10:56 AM

Why Shares of Arrowhead Research Corp. Briefly Spiked Today

Arrowhead Research Corp. stock shot up briefly this morning. Here's why.

NL

Article

gbudwell published an article 9:27 AM

2 Speculative Biotechs That Could Be Well Worth the Risk

Celladon Corp. and Exelixis Inc. are two speculative biotech stocks that might be worth their substantial risks.

Wed Apr 8

NL

Article

gbudwell published an article 10:51 AM

Why Second Sight Medical Products, Inc. Stock Bolted Higher Today

Shares of Second Sight Medical Products rose by over 15% today. Here's why.

Tue Apr 7

NL

Article

gbudwell published an article 10:49 AM

Why Shares of Ocular Therapeutix, Inc. Crumbled Today

Shares of Ocular Therapeutix cratered today. Here's why.

Mon Apr 6

NL

Article

gbudwell published an article 10:10 AM

Why uniQure N.V. Stock Skyrocketed Today

Shares of uniQure burst higher today. Here's why.

NL

Article

gbudwell published an article 12:50 AM

Should You Buy Marijuana Stocks Right Now? A Legal Expert Weighs In

Aaron Lachant, a medical marijuana legal expert, gives his opinion on the biggest risks and opportunities for this high growth industry moving forward.

Thu Apr 2

NL

Article

gbudwell published an article 8:04 AM

Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?

AbbVie is reportedly still interested in acquiring additional assets to help it over the Humira patent cliff hump. Would Acadia Pharmaceuticals be a good match for this big pharma?

Wed Apr 1

NL

Article

gbudwell published an article 10:58 AM

Why Dyax Corp. Stock Exploded Higher Today

Shares of rare disease drugmaker Dyax Corp. soared today on positive clinical news. Here's what investors need to know going forward.

NL

Article

gbudwell published an article 3:24 AM

Sarepta Therapeutics Inc.'s CEO Exits: Is the Stock Now a Buy?

Sarapeta's CEO abruptly left the company yesterday. With a new face at the helm, can this speculative biotech finally change course?

Tue Mar 31

NL

Article

gbudwell published an article 11:05 AM

Why Shares of Synta Pharmaceuticals Corp. Sank Today

Synta Pharmaceutical's shares cratered today. Here's why.

Mon Mar 30

NL

Article

gbudwell published an article 1:31 PM

Why Auspex Pharmaceuticals, Inc. Stock Soared Today

Shares of the orphan drugmaker Auspex Pharmaceuticals burst higher today by over 40%. Here's why.

Rule Breakers article.

gbudwell published an update. 12:34 PM

NL

Article

gbudwell published an article 11:40 AM

Why Catamaran Corporation Stock Soared Today

Shares of the pharmacy benefits manager Catamaran skyrocketed today. Here's why.

Fri Mar 27

NL

Article

gbudwell published an article 8:42 PM

Has the Biotech Bubble Already Popped?

Fear about a bubble in biotech is growing, keeping many investors on the sidelines. Is this fear warranted?

Rule Breakers article.

gbudwell published an update. 11:12 AM

NL

Article

gbudwell published an article 10:54 AM

Why BioMarin Pharmaceuticals Inc. Stock Is Surging Today

BioMarin's shares are soaring today. Here's why.

NL

Article

gbudwell published an article 8:37 AM

1 Clinical-Stage Biotech Stock That Could Make You Into a Millionaire

Celladon Corp. is nearing a make or break moment in its history with the release of its CUPID-2 top-line data for the cardiovascular gene therapy Mydicar. Here's why this speculative biotech is worth a deeper look by risk-tolerant investors.

NL

Article

gbudwell published an article 12:05 AM

Is AbbVie Inc. Stock About to Crash?

AbbVie has been an amazing growth story since its inception in 2013. However, this trend might be about to come to abrupt end. Here's why.

Thu Mar 26

NL

Article

gbudwell published an article 5:14 AM

Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?

Gilead Sciences has become a battleground stock due to the uncertainty surrounding the future of the hep C market. Here is a look at why the bears might be right in their assessment of this top biotech stock.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75233
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 5
Best Pick RXII (+9.56)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts